| Literature DB >> 29273919 |
Carolina Díaz-Cárdenas1, Angela Cantillo2, Laura Yinneth Rojas3, Tito Sandoval3, Susana Fiorentino3, Jorge Robles4, Freddy A Ramos5, María Mercedes Zambrano2, Sandra Baena6.
Abstract
In order to select class="Species">halophilic microorganisms as a source of compounds with <class="Chemical">span class="Disease">cytotoxic activities, a total of 135 bacterial strains were isolated from water and sediment samples collected from the Zipaquirá salt mine in the Colombian Andes. We determined the cytotoxic effects of 100 crude extracts from 54 selected organisms on the adherent murine mammary cell carcinoma 4T1 and human mammary adenocarcinoma MCF-7 cell lines. These extracts were obtained from strains of Isoptericola, Ornithinimicrobium, Janibacter, Nesterenkonia, Alkalibacterium, Bacillus, Halomonas, Chromohalobacter, Shewanella, Salipiger, Martellela, Oceanibaculum, Caenispirillum and Labrenzia. The extracts of 23 strains showed an IC50 of less than 100 μg mL-1. They were subsequently analyzed by LC/MS allowing dereplication of 20 compounds. The cytotoxic effect was related to a complex mixture of diketopiperazines present in many of the extracts analyzed. The greatest cytotoxic activity against both of the evaluated cell lines was obtained from the chloroform extract of Labrenzia aggregata USBA 371 which had an IC50 < 6 μg mL-1. Other extracts with high levels of cytotoxic activity were obtained from Bacillus sp. (IC50 < 50 μg mL-1) which contained several compounds such as macrolactin L and A, 7-O-succinoylmacrolactin F and iturin. Shewanella chilikensis USBA 344 also showed high levels of cytotoxic activity against both cell lines in the crude extract: an IC50 < 15 μg mL-1 against the 4T1 cell line and an IC50 < 68 μg mL-1 against the MCF-7 cell line. Nesterenkonia sandarakina CG 35, which has an IC50 of 118 µg mL-1 against 4T1, is a producer of diketopiperazines and 1-acetyl-β-carboline. Also, Ornithinimicrobium kibberense CG 24, which has IC50 < 50 μg mL-1, was a producer of diketopiperazines and lagunamycin. Our study demonstrates that these saline environments are habitats of halophilic and halotolerant bacteria that have previously unreported cytotoxic activity.Entities:
Keywords: Cytotoxic activity; Halophilic bacteria; Phylogenetic diversity; Secondary metabolism
Year: 2017 PMID: 29273919 PMCID: PMC5741568 DOI: 10.1186/s13568-017-0527-6
Source DB: PubMed Journal: AMB Express ISSN: 2191-0855 Impact factor: 3.298
Fig. 1Distribution of the relative abundance of the Bacteria and Archaea strains isolated at Zipaquirá salt mine
Fig. 2Distribution of the relative abundance of the bacteria genera isolated at Zipaquirá salt mine
Cytotoxic activities of evaluated strains
| Strain ID | Closed type strain (Accession No) (% similarity) | Culture medium | Extraction solvent | Cytotoxic activity of crude extracts IC50 (µg mL−1) | |
|---|---|---|---|---|---|
| Cellular line | |||||
| 4T1 | MCF7 | ||||
| Actinobacteria | |||||
| CG 23 | TSB 8% (w/v) NaCl | Chloroform | > 250 | 146.0 | |
| TSB 8% (w/v) NaCl | Ethyl acetate | > 250 | 53.9 | ||
| TSB | Chloroform | – | – | ||
| TSB | Ethyl acetate | – | – | ||
| CG 24 | TSB 8% (w/v) NaCl | Chloroform | 106.0 | > 250 | |
| TSB | Chloroform | – | – | ||
| TSB | Ethyl acetate | > 250 | 57.2 | ||
| CG 12 | TSB 8% (w/v) NaCl | Chloroform | 226 | 34.2 | |
| TSB 8% (w/v) NaCl | Ethyl acetate | > 250 | > 250 | ||
| CG 35 | TSB 8% (w/v) NaCl | Chloroform | 117.8 | 188.6 | |
| TSB 8% (w/v) NaCl | Ethyl acetate | > 250 | > 250 | ||
| CG 28 | TSB 8% (w/v) NaCl | Chloroform | – | – | |
| TSB 8% (w/v) NaCl | Ethyl acetate | – | – | ||
| CG 20 | TSB 8% (w/v) NaCl | Chloroform | – | – | |
| TSB 8% (w/v) NaCl | Ethyl acetate | – | – | ||
| TSB | Chloroform | – | – | ||
| Firmicutes | |||||
| CG 6 | Marine broth | Chloroform | 134.3 | 59.9 | |
| TSB | Chloroform | – | – | ||
| TSB | Ethyl acetate | > 250 | 118.8 | ||
| CG 3 | TSB | Chloroform | – | – | |
| TSB | Ethyl acetate | > 250 | 87.3 | ||
| USBA 882 | Modified marine broth | Ethyl acetate | 192.0 | NT | |
| USBA 899 | TSB 3% (w/v) NaCl | Chloroform | – | – | |
| TSB 3% (w/v) NaCl | Ethyl acetate | – | – | ||
| CG 13 | TSB 80 | Chloroform | – | – | |
| TSB 80 | Ethyl acetate | > 250 | 200.5 | ||
| CG 25 | TSB 80 | Chloroform | – | – | |
| TSB 80 | Ethyl acetate | > 250 | 56.1 | ||
| CG 36 | TSB | Chloroform | 173.2 | 8.8 | |
| CG 42 | TSB 3% (w/v) NaCl | Chloroform | – | – | |
| TSB | Chloroform | – | – | ||
| CG 69 | TSB | Chloroform | > 250 | 224.0 | |
| CG 11 | TSB | Chloroform | – | – | |
| TSB | Ethyl acetate | > 250 | > 250 | ||
| CG 7 | TSB | Chloroform | – | – | |
| TSB | Ethyl acetate | > 250 | > 250 | ||
| CG 69 | TSB 3% (w/v) NaCl | Chloroform | – | – | |
| TSB 3% (w/v) NaCl | Ethyl acetate | – | – | ||
| CG 15 | TSB | Chloroform | > 250 | 136 | |
| TSB | Ethyl acetate | > 250 | 42.0 | ||
| Marine broth | Chloroform | – | – | ||
| Marine broth | Ethyl acetate | > 250 | 65.6 | ||
| USBA 866 | Modified marine broth | Chloroform | > 250 | 185.7 | |
| Modified marine broth | Ethyl acetate | 48.3 | 65.7 | ||
| USBA 867 | Modified marine broth | Ethyl acetate | > 250 | 134.8 | |
| USBA 868 | Modified marine broth | Ethyl acetate | 56.2 | 76.2 | |
| CG 22 | TSB | Chloroform |
|
| |
| TSB | Ethyl acetate | 21.7 | 75.5 | ||
| CG 63 | TSB 80 | Chloroform | 107 | 76.4 | |
| CG 31 | TSB 8% (w/v) NaCl | Ethyl acetate | 25.4 | 144.4 | |
| CG 57 | TSB | Chloroform | – | – | |
| TSB | Ethyl acetate | – | – | ||
| CG 74 | TSB 8% (w/v) NaCl | Chloroform | – | – | |
| TSB 8% (w/v) NaCl | Ethyl acetate | – | – | ||
| CG 86 | TSB 8% (w/v) NaCl | Chloroform | – | – | |
| TSB 8% (w/v) NaCl | Ethyl acetate | – | – | ||
| CG 88 | TSB 8% (w/v) NaCl | Chloroform | – | – | |
| TSB 8% (w/v) NaCl | Ethyl acetate | – | – | ||
| Gammaproteobacteria | |||||
| CG 76 | TSB 4% (w/v) NaCl | Ethyl acetate | > 250 | 96.7 | |
| CG X | TSB 8% (w/v) NaCl | Chloroform | 82.3 | 101.3 | |
| CG 60 | TSB 8% (w/v) NaCl | Chloroform | – | – | |
| TSB 8% (w/v) NaCl | Ethyl acetate | > 250 | > 250 | ||
| CG 83 | TSB 8% (w/v) NaCl | Chloroform | – | – | |
| TSB 8% (w/v) NaCl | Ethyl acetate | – | – | ||
| USBA 856 | Modified marine broth | Chloroform | 4.3 | 217.1 | |
| Modified marine broth | Ethyl acetate | – | – | ||
| TSB | Ethyl acetate | – | – | ||
| CG 78 | TSB 8% (w/v) NaCl | Chloroform | – | – | |
| TSB 8% (w/v) NaCl | Ethyl acetate | – | – | ||
| CG 66 | TSB 8% (w/v) NaCl | Chloroform | – | – | |
| TSB 8% (w/v) NaCl | Ethyl acetate | – | – | ||
| USBA 873 | TSB 3% (w/v) NaCl | Chloroform | – | – | |
| TSB 3% (w/v) NaCl | Ethyl acetate | – | – | ||
| CG 50 | TSB 8% (w/v) NaCl | Chloroform | 158.6 | 115 | |
| TSB 8% (w/v) NaCl | Ethyl acetate | – | – | ||
| CG 72 | TSB 8% (w/v) NaCl | Chloroform | – | – | |
| TSB 8% (w/v) NaCl | Ethyl acetate | – | – | ||
| CG 55 | TSB 8% (w/v) NaCl | Chloroform | – | – | |
| TSB 8% (w/v) NaCl | Ethyl acetate | 69.3 | 137.6 | ||
| USBA862 | TSB 3% (w/v) NaCl | Chloroform | – | – | |
| TSB 3% (w/v) NaCl | Ethyl acetate | – | – | ||
| USBA 861 | TSB 3% (w/v) NaCl | Chloroform | – | – | |
| TSB 3% (w/v) NaCl | Ethyl acetate | > 250 | > 250 | ||
| USBA 896 | TSB 3% (w/v) NaCl | Chloroform | – | – | |
| TSB 3% (w/v) NaCl | Ethyl acetate | – | – | ||
| USBA 344 | TSB 3% (w/v) NaCl | Chloroform | 5.3 | 67.9 | |
| TSB 3% (w/v) NaCl | Ethyl acetate | 15.3 | 21.8 | ||
| CG 65 | TSB 8% (w/v) NaCl | Chloroform | – | – | |
| TSB 8% (w/v) NaCl | Ethyl acetate | – | – | ||
| Alphaproteobacteria | |||||
| CG 82 | TSB | Ethyl acetate | > 250 | > 250 | |
| USBA 36 | TSB 5% (w/v) NaCl | Chloroform | 173.2 | 8.8 | |
| USBA 85 | TSB | Chloroform | 69.6 | 90.5 | |
| TSB | Ethyl acetate | 29.5 | 74.1 | ||
| USBA 857 | Marine broth | Chloroform | > 250 | > 250 | |
| USBA 371 | TSB 3% (w/v) NaCl | Chloroform | 5.5 | 4.5 | |
Cytotoxic activities of fractions from the crude extracts
| Strain ID | Crude extract/fraction | Extraction solvent | Cytotoxic activity of fractions IC50 (µg mL−1) | |
|---|---|---|---|---|
| Cellular line | ||||
| 4T1 | MCF7 | |||
| CG 35 |
|
|
|
|
| F 2.1 | Hexane:ethyl acetate | 73.8 | 87.9 | |
| F 2.2 | Hexane:ethyl acetate | 69.6 | 68.4 | |
| F 4.1 | Ethyl acetate | 88.2 | 247.2 | |
| F 5.2 | Ethyl acetate:methanol | 84.5 | 79.7 | |
| F 5.3 | Ethyl acetate:methanol | 72.6 | 96.3 | |
| CG 24 |
|
| > 250 |
|
| F 6.2 | Methanol | > 250 | 138.6 | |
| CG 22 |
|
|
|
|
| F 6.1 | Methanol | > 250 | 44.8 | |
| CG 63 |
|
|
|
|
| F 4.1 | Ethyl acetate | ND | 44.4 | |
| CG 50 |
|
| 158.6 | 115 |
| F 6.1 | Methanol | 31.2 | > 250 | |
| USBA 344 |
|
|
|
|
| F 3.2 | Hexane:ethyl acetate | 229.2 | 80.3 | |
| USBA 371 |
|
| 5.5 | 4.5 |
| F 4.1 | Ethyl acetate | 15.2 | 26.6 | |
| F 4.2 | Ethyl acetate:methanol | 8.9 | 16.3 | |
| F 5.1 | Ethyl acetate:methanol | 7.2 | 14.5 | |
| F 6.1 | Methanol | 28.7 | 49.0 | |
ND No data
Fig. 3Cytotoxic effects and IC50 of crude extracts and fraction from strains CG 35 (a), CG 24 (b), CG 22 (c), CG 63 (d), USBA 344 (e), and USBA 371 (f) on the adherent murine mammary cell carcinoma 4T1 and human mammary adenocarcinoma MCF-7 cell lines. IC50 was performed using eight dilutions ranging from 250 to 31.25 μg mL−1. DOXO Doxorubicin at concentration of 5 μM was used as a positive control
Fig. 4Compounds identified by LC/MS from strains CG 35 (a), CG 24 (b), CG 22 (c), CG 63 (d), and CG 50 (e). a 1-acetyl-β-carboline 1, cyclo(2-OHPro-Phe) 2, cyclo(Pro-Phe) 3, brevianamide F 4, cyclo(Leu-Phe) 5, cyclo(Val-Phe) 6, and cyclo(Phe-Phe) 7, cyclo(Pro-Leu) 8; b cyclo(Trp-Tyr), lagunamycin 10; c cyclo(His-Pro) 11; Surfactin 12; d cyclo(Pro-Val) 13, macrolactin 14, succinoylmacrolactin 15, and iturin 16; e cyclo(Pro-Ala) 17, cyclo(Pro-Thr) 18, cyclo(Ala-Phe) 19, cyclo(Pro-Tyr) 20